OTC · HGENQ
Humanigen, Inc.
$0.00$0.00 (0.0%)
Humanigen, Inc.: Healthcare · Biotechnology.
Loading market information…
OTC · NMMCF · USD
Stock price, dividends, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NMC Health plc’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
NMC Health plc’s forward annual dividend is $0.18 per share, paid annual. The forward yield is 1,810,000.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow NMC Health plc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
NMC Health plc operates as a significant healthcare provider, offering a broad spectrum of medical services across the United Arab Emirates, the United Kingdom, Spain, and other global regions. The company maintains and supervises a diverse network of healthcare facilities, including hospitals, general medical centers, long-term care institutions, day-surgery clinics, fertility treatment centers, and agencies for home health services. Its range of medical offerings includes comprehensive diagnostic services, inpatient and outpatient care. Furthermore, NMC Health plc specializes in gynecology, obstetrics, and human reproduction, delivering both clinical services and pioneering research in these domains. Beyond direct patient care, the organization also provides management expertise for hospitals and engages in the retail of pharmaceutical products. NMC Health plc was founded in 1974 and is currently headquartered in London, United Kingdom.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00$0.00 (0.0%)
Humanigen, Inc.: Healthcare · Biotechnology.
$1.01$0.00 (0.0%)
Cantabio Pharmaceuticals, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
Diagnocure, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$8.30-$16,591.70 (-99.95%)
QSAM Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.95% below the high.
$0.00$0.00 (0.0%)
NutraLife BioSciences, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Genesis Healthcare, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.97% below the high.
$0.00$0.00 (0.0%)
Advanzeon Solutions, Inc.: Healthcare · Medical - Care Facilities.
$0.00$0.00 (0.0%)
Rapid Therapeutic Science Laboratories, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.29% below the high.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
